Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02097290 · ClinicalTrials.gov registry record · NA
Evaluation of Automatic Threshold Algorithms
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 216
- Enrollment target
NCT02097290 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 216 participants.
The verdict
NCT02097290, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
Study Summary
This study will evaluate the PaceSafe Right Ventricular Autothreshold (RVAT) and Left Ventricular Autothreshold (LVAT) features for AUTOGEN Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices.
Interventions
- DEVICE CRT-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02097290
The ClinicalTrials.gov registry entry for NCT02097290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CRT-D is the first listed.
NCT02097290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02097290 about?
NCT02097290 is a clinical study titled "Evaluation of Automatic Threshold Algorithms". This study will evaluate the PaceSafe Right Ventricular Autothreshold (RVAT) and Left Ventricular Autothreshold (LVAT) features for AUTOGEN Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices.
What is the current status of trial NCT02097290?
This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2014-04. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02097290?
The interventions under investigation include: CRT-D (DEVICE).
Who is sponsoring clinical trial NCT02097290?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.